AlexanderBorowskyMD

Anatomic Pathology, Clinical Pathology

Associate Professor, Pathology, UC, Davis School of Medicine

Dr. Borowsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4400 V St
Pathology Building
Sacramento, CA 95817
Phone+1 916-734-2525

Vanderbilt University Medical CenterResidency, Pathology-Anatomic and Clinical, 1994 - 1997
Vanderbilt University School of MedicineClass of 1994

PubMed

Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer.
Michael J Campbell, Denise M Wolf, Christina Yau, Lamorna Brown-Swigart, Julie Wulfkuhle
Cell Reports. Medicine. 2024-11-19
Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming.
Yatian Yang, Xiong Zhang, Demin Cai, Xingling Zheng, Xuan Zhao
Proceedings of the National Academy of Sciences of the United States of America. 2024-10-15
Peripheral-derived regulatory T cells contribute to tumor-mediated immune suppression in a nonredundant manner.
Md Moazzem Hossain, Paul King, Justin Hackett, Herve C Gerard, Rajmund Niwinski
Proceedings of the National Academy of Sciences of the United States of America. 2024-09-03

Join the All of Us Research Program and Be One in a Million!September 8th, 2021
Follow-up: Sorting Out the Results of Breast BiopsyMarch 28th, 2016
Doctors Often Disagree on When to Call Abnormal Breast Cells CancerMarch 21st, 2016
Join now to see all